Tag: Quality-adjusted life year

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Quality-adjusted life year

Hart: Lower Drug Cost Act would cost NJ more than 70K jobs

Added to Collection on: 2021-06-14 11:03:45

Tags for this article:

Health
Pharmaceutical industry
Healthcare reform in the United States
Drug pricing
Health economics
Elijah Cummings Lower Drug Costs Now Act
Medication costs
Medicare
Medication
Quality-adjusted life year

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Added to Collection on: 2021-07-23 19:41:15

Tags for this article:

Health
Health care quality
Health economics
Orphan drugs
Pharmacy
Alexion Pharmaceuticals
AstraZeneca
Eculizumab
Institute for Clinical and Economic Review
Quality-adjusted life year
Myasthenia gravis
Oxford–AstraZeneca COVID-19 vaccine
Soliris

Click the tags to see associated articles and topics

View Article Details
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow ...

Added to Collection on: 2021-08-12 00:56:15

Tags for this article:

Health
Organic compounds
Health care quality
Health economics
Antiviral drugs
COVID-19 drug development
Remdesivir
Quality-adjusted life year
Incremental cost-effectiveness ratio

Click the tags to see associated articles and topics

View Article Details
Price of COVID treatments from Pfizer, Merck, GSK align with patient benefits -report - Yahoo News

Added to Collection on: 2022-02-03 19:10:32

Tags for this article:

Health
COVID-19 drug development
Health care quality
Health economics
Antiviral drugs
Costs
Institute for Clinical and Economic Review
Sotrovimab
Molnupiravir
Quality-adjusted life year
SARS-CoV-2 Omicron variant
Merck & Co.

Click the tags to see associated articles and topics

View Article Details
Price of COVID treatments from Pfizer, Merck, GSK align with patient benefits -report | Reuters

Added to Collection on: 2022-02-04 09:37:13

Tags for this article:

Health
COVID-19 drug development
Health economics
Antiviral drugs
Health care quality
Costs
Sotrovimab
Institute for Clinical and Economic Review
Molnupiravir
SARS-CoV-2 Omicron variant
Quality-adjusted life year
Merck & Co.

Click the tags to see associated articles and topics

View Article Details
Industry-funded studies more likely to find new treatments cost effective - Brighter World

Added to Collection on: 2022-06-23 16:06:10

Tags for this article:

Health
Health economics
Health care quality
Pharmacy
Quality-adjusted life year
Pharmaceutical industry
Cost-effectiveness analysis
Feng Xie

Click the tags to see associated articles and topics

View Article Details
CAR-T Therapies Cost Prohibitive for Diffuse Large B-Cell Lymphoma Treatment

Added to Collection on: 2022-12-21 01:46:41

Tags for this article:

Health
Articles
Health economics
Healthcare quality
Costs
RTT
Cancer treatments
Incremental cost-effectiveness ratio
Chimeric antigen receptor T cell
Quality-adjusted life year
Doxorubicin
Axicabtagene ciloleucel
United States

Click the tags to see associated articles and topics

View Article Details
Prostatype® can contribute to over 600 MSEK in annual health economy benefit just in ...

Added to Collection on: 2024-10-03 14:28:54

Tags for this article:

Health economics
Health care quality
Quality-adjusted life year
Prostate cancer
Cost-effectiveness analysis
Cancer
Institute for Clinical and Economic Review
Cost–utility analysis
Prostatype Genomics AB
Sweden

Click the tags to see associated articles and topics

View Article Details
Are expensive drugs worth it? Rolling out new medicines may be too costly to other patients' health

Added to Collection on: 2024-12-14 23:24:43

Tags for this article:

Pharmacy
Health economics
Health care quality
Pharmaceuticals policy
Drug pricing
Quality-adjusted life year
National Institute for Health and Care Excellence
Medication costs
Pharmaceutical industry
National Health Service
NHS Scotland
Medication
Huseyin Naci
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Iptacopan Is a Cost-Effective Therapy in Improving Quality of Life in PNH

Added to Collection on: 2025-02-21 20:21:55

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Health care quality
Paroxysmal nocturnal hemoglobinuria
Quality-adjusted life year
Iptacopan
Eculizumab
Ravulizumab
Danicopan

Click the tags to see associated articles and topics

View Article Details